Why Biogen Stock Popped Today | The Motley Fool
Author Bio A Fool since 2019, Prosper's writing focuses primarily on the healthcare sector. Passionate about teaching and learning, he enjoys helping others make better decisions about their finances -- and enjoys it just as much when they return the favor. In his free time, you'll find him curling up with a good book or doing math. What happened? On Friday morning, Biogen (NASDAQ:BIIB) released an update regarding its Biologics License Application (BLA) for aducanumab as a potential treatment for Alzheimer's disease (AD). The drugmaker wasn't too forthcoming with det...
Source: fool.com